Health Sciences Grants

Health Sciences Research Awards and Grants

Title Type $ Amount Activity Investigator Unit Sponsor Date
Infertility and Long-Term Health Outcomes Among Hispanic Women with Mexican Heritage Grant 2,216,256.00 Research Leslie Farland Epidemiology and Biostatistics Eunice Kennedy Shriver National Institute of Child Health and Human Development 08/2024
MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene Expression Profiles: An Adaptable Registry (FLEX Registry) Contract 39,090.00 Clinical Trial Jennifer Segar Cancer Center Division Agendia, Inc. 08/2024
Medicare Rural Hospital Flexibility Cooperative Agreement 4,427,420.00 Other Sponsored Activity Daniel Derksen Center for Rural Health Health Resources and Services Administration 08/2024
Pima CARES (Pima County Advanced Response Entry System) Contract 266,632.00 Other Sponsored Activity Allison Huff Family and Community Medicine Pima County Health Department 08/2024
POLARx PAS: BSC Cardiac Cryoablation System Post-Approval Study Contract 446,678.48 Clinical Trial Wilber Su COM Phx Internal Medicine Boston Scientific Corporation 08/2024
Reconfigurable MRI Technology For Safe and High-Resolution Imaging of Deep Brain Stimulation at 3T Grant 69,999.00 Research Julie Pilitsis Neurosurgery Northwestern University 08/2024
RECOVER-ENERGIZE: A Platform Protocol for Evaluation of Interventions for Exercise Intolerance in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Contract 167,856.00 Clinical Trial Franz Rischard Medicine Duke University 08/2024
Recruitment of Local Health Departments for PH WINS Grant 22,000.00 Other Sponsored Activity Kelly Reynolds Community Environment & Policy Vose River Charitable Fund 08/2024
Refining Tamoxifen Dose for Premenopausal Breast Cancer Prevention: Renaissance, a Phase II Trial Contract 38,400.00 Clinical Trial Hsiao-Hui Chow Cancer Center Division Northwestern University 08/2024
Sex Steroids, Kisspeptin and Regulation of GnRH Grant 448,282.00 Research Sally Radovick Pediatrics Eunice Kennedy Shriver National Institute of Child Health and Human Development 08/2024
SOS-AMI Multi-Center, Double-Blind, Randomized , Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Self-Administered Subcutaneous Selatogrel for Prevention of All-Cause D Contract 447,608.00 Clinical Trial Deepak Acharya Sarver Heart Center Idorsia Pharmaceutical (Switzerland) 08/2024
Surveillance of Spina Bifida across the Lifespan Cooperative Agreement 340,000.00 Other Sponsored Activity Jennifer Andrews Pediatrics Centers for Disease Control and Prevention 08/2024
The DECIDE Registry: AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management Contract 119,498.00 Clinical Trial Michael Morris COM Phx Radiology HeartFlow, Inc. 08/2024
Therapeutics Development Center Award Grant 150,472.00 Research Cori Daines Asthma/Airway Disease Rsch Ctr Cystic Fibrosis Foundation 08/2024
ThinkHumanTV: Entertainment-based PsychoEducation to Enhance Emotion Skills and Reduce Psychiatric Morbidity Grant 49,993.00 Research Karen Weihs Psychiatry The Institute for Mental Health Research 08/2024
To Development a Live Attenuated Vaccine Against Coccidioidomycosis Through a Phase 1 Clinical Trial That Will Demonstrate Safety and Immunogenicity in Healthy Subjects Without Prior Exposure to the C Contract 705,508.00 Research John Galgiani Valley Fever Ctr for Excellnc Anivive Lifesciences, Inc 08/2024
Towards Screening With High-resolution, Low-dose, Dedicated Breast CT Grant 3,258,120.00 Research Srinivasan Vedantham Medical Imaging National Cancer Institute 08/2024
A Phase 1b/2 Open-Label Study of Disitamab Vedotin Monotherapy or in Combination with Other Anti-Cancer Therapies in Solid Tumors Contract 723,979.32 Clinical Trial Jennifer Segar Cancer Center Division Seagen Inc. 07/2024
A Phase 2, Randomized, Open-label Study of Onvansertib in Combination with FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-line Tre Contract 548,570.00 Clinical Trial Aaron Scott Cancer Center Division Pfizer, Incorporated 07/2024
A Phase 2b Multicenter, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Moderately to Severely Active Ulcerative Colitis Eff Contract 2,600.00 Clinical Trial Sasha Taleban Medicine Janssen Research & Development, LLC 07/2024